Choosing, sizing, and seating the right LMA-type device — from suitability screening to leak-pressure confirmation
The supraglottic airway (SGA) — the family of devices descended from the original laryngeal mask airway (LMA), invented by Archie Brain in 1981 — sits above the vocal cords and forms a seal around the laryngeal inlet rather than passing through it. This makes insertion faster, less stimulating, and largely blind, but it also means the airway is not protected from below by a cuff sealed against the tracheal wall. Suitability screening is therefore the first and most consequential decision point: choosing an SGA when it is not appropriate is one of the most common preventable contributors to aspiration and hypoventilation events in modern anesthesia.
An SGA is a conduit that sits in the hypopharynx, its distal cuff or gel cushion resting against the upper esophageal sphincter and its bowl encircling the laryngeal inlet. When correctly seated, it provides a low-resistance path for spontaneous or positive-pressure ventilation without the laryngoscopy, vocal cord instrumentation, and tracheal cuff of an endotracheal tube (ETT).
What it provides: a patent airway, a conduit for volatile anesthetic and oxygen delivery, and — in second-generation designs — a separate channel that vents the esophagus and allows gastric decompression.
What it does NOT reliably provide: a tracheal seal. Even a well-seated SGA leaves the trachea open to whatever sits above the cuff. If gastric contents reflux into the hypopharynx, an SGA offers only partial, device-dependent protection — far less than a cuffed ETT positioned below the cords.
Three domains drive the suitability decision:
Fasting/aspiration risk — Standard ASA fasting (6 h solids, 2 h clear fluids) is reassuring but not absolute. Independent risk elevators include: symptomatic reflux/hiatal hernia, delayed gastric emptying (diabetic gastroparesis, opioid use, bowel obstruction), pregnancy beyond the first trimester, and emergency/non-fasted status.
Body habitus — Elevated BMI increases intra-abdominal pressure and lowers lower-esophageal-sphincter competence, both of which raise reflux risk, and can also make mask seal and positive-pressure ventilation less reliable. Most guidelines regard BMI up to ~30–35 as reasonable for SGA use in appropriate cases; higher BMI shifts the balance toward ETT, especially for longer or laparoscopic cases.
Procedure factors — Duration (SGAs are best suited to shorter-to-moderate cases; extended use raises mucosal pressure injury risk), patient position (supine and mild head-up positions are favorable; steep Trendelenburg, prone, or lateral positions raise both reflux and dislodgement risk), and the anticipated peak airway pressure the procedure will require (laparoscopic pneumoperitoneum raises intra-abdominal pressure and required ventilating pressure simultaneously).
A supraglottic airway is not the right tool when: aspiration risk is high (full stomach, active vomiting, bowel obstruction, severe reflux), the procedure requires high or unpredictable peak airway pressures beyond the device leak pressure, the surgical position removes ready access to the airway (prone, some lateral procedures) or restricts the ability to intervene rapidly if the airway is lost, the case is long enough that mucosal cuff pressure over time becomes a concern, or the patient has limited mouth opening or upper airway pathology that prevents correct device seating.
Many of these are relative rather than absolute: a second-generation device with a gastric drain and a strict leak-pressure safety margin can extend SGA use into moderate-risk territory that would have excluded a first-generation device outright. The screening step in this simulator therefore feeds directly into the device-type decision in Stage 2.
A useful mental model: the fasting history, BMI, and procedure profile do not produce a single yes/no answer — they produce an aspiration risk score. That score is the single variable that most influences whether an SGA is used at all, and if so, which generation of device is required.
The single biggest design evolution in supraglottic airways since the classic LMA is the addition of a dedicated gastric drain channel — a second, separate tube running parallel to the airway conduit that opens at the tip of the device, aligned with the esophagus. This one feature defines the split between "first-generation" devices (classic LMA, LMA Unique) and "second-generation" devices (LMA ProSeal, LMA Supreme, i-gel, LMA Protector), and it is the single most important factor in matching a device to aspiration risk.
The original LMA and its direct descendants (LMA Classic, LMA Unique, LMA Flexible) consist of a single airway tube terminating in an elliptical, inflatable silicone or PVC cuff that seats around the laryngeal inlet. There is no separate channel to the esophagus.
Strengths: simple, inexpensive, fast to insert, well studied over four decades of use, adequate for short low-risk procedures in fasted patients.
Limitations: lower achievable seal pressure (typically 15–20 cmH₂O), no way to pass a gastric tube to decompress the stomach or vent regurgitated contents, and no independent confirmation channel to verify correct tip position relative to the esophagus.
Beginning with the LMA ProSeal (2000) and extending through the LMA Supreme, i-gel, and LMA Protector, second-generation devices add a drain tube that runs from a port near the patient connector down to an opening at the device tip, positioned to sit directly over the upper esophageal sphincter when the device is correctly seated.
This channel serves three functions: (1) it allows passage of an orogastric tube to actively decompress the stomach, reducing regurgitation risk and improving ventilation mechanics; (2) it provides a route for any refluxed gastric contents to vent away from the airway rather than pooling around the laryngeal inlet; and (3) a bubble test or free flow of gastric contents through the drain, absent from the airway channel, is itself a confirmatory sign of correct tip placement.
Second-generation cuffs (many double-cuffed or gel-filled rather than air-filled, as in the i-gel) also generally achieve substantially higher seal pressures — often 26–34 cmH₂O versus 15–20 cmH₂O for first-generation masks — because the cuff geometry more completely occludes the periglottic space.
The device-type decision reduces to two questions: how high is aspiration risk, and how much airway pressure will this procedure require?
Low aspiration risk score (0–3) with modest ventilation pressure needs: a first-generation device is a reasonable, cost-effective choice for short spontaneous-ventilation or low-pressure positive-pressure cases.
Moderate-to-high aspiration risk score (4–10), laparoscopic or robotic procedures requiring pneumoperitoneum, obesity, or any case where positive-pressure ventilation above ~15–18 cmH₂O is anticipated: a second-generation device is preferred or required, both for the higher achievable seal pressure and for the gastric decompression pathway.
At the highest end of the risk spectrum (active regurgitation, unfasted emergency patients, bowel obstruction), no supraglottic airway — however advanced — substitutes for a cuffed endotracheal tube with rapid-sequence induction.
Supraglottic airways are sized to a small number of discrete bowl/cuff dimensions, each validated by the manufacturer against a body-weight range rather than a continuous measurement. Choosing correctly matters: an undersized device seats poorly and leaks; an oversized device can fold, malrotate, or exert excess pressure against pharyngeal and laryngeal structures, risking sore throat, nerve palsy, or poor ventilation despite looking "correctly" placed on external inspection.
Unlike endotracheal tubes, which are sized continuously by internal diameter and chosen from formulas or age tables, supraglottic airways are manufactured in a fixed set of discrete sizes (commonly 1, 1.5, 2, 2.5 for infants and children, and 3, 4, 5 — sometimes 6 — for adults). Each size corresponds to a bowl and cuff engineered to match the average pharyngeal and periglottic geometry of patients within a given weight band, established through the manufacturer's original cadaver and clinical fit studies.
Body weight is used as the proxy because pharyngeal volume correlates with weight more reliably, and more practically at the point of care, than height, BMI, or direct airway measurement. It is an imperfect proxy — unusually short, tall, or anatomically atypical patients may fit better one size up or down from the weight-predicted size — which is why clinical judgment and a size immediately above and below should always be available at induction.
Undersized device: insufficient bowl volume to fully occlude the periglottic space, leading to a lower achievable seal pressure, higher leak rates during positive-pressure ventilation, and a higher chance the device rotates or migrates during the case.
Oversized device: the bowl may fold on insertion, fail to pass the tip fully into the hypopharynx, or — if forced — exert excess pressure against the tongue base, epiglottis, and pharyngeal mucosa. Reported consequences of prolonged excess cuff pressure include sore throat (the most common minor complication, reported in a meaningful minority of cases), dysphagia, and, less commonly, transient lingual, hypoglossal, or recurrent laryngeal nerve palsy.
Cuff inflation practice compounds the sizing decision: cuffs (where inflatable) should be inflated to the minimum volume that achieves an adequate seal, guided by a manometer to a target intracuff pressure of approximately 40–60 cmH₂O rather than by a fixed injected volume — overinflation is a common and avoidable source of pharyngolaryngeal morbidity even with a correctly sized device.
1. Assess aspiration risk (fasting status, reflux history, BMI, procedure position/duration) → assign a risk score. 2. If risk is high, procedure requires high sustained airway pressure, or absolute contraindications are present → abandon the SGA pathway, secure the airway with a cuffed endotracheal tube instead. 3. If an SGA is appropriate, select device generation: low risk / low pressure need → first-generation acceptable; moderate-to-high risk or laparoscopic/high-pressure ventilation → second-generation with gastric drain preferred. 4. Select size from the manufacturer weight band for the chosen device family; keep one size above and below open on the table. 5. Insert, seat, and inflate the cuff (if applicable) to the target manometer pressure — not a fixed volume. 6. Confirm placement: chest rise, square-wave capnography trace, absence of gastric insufflation sound, and (for 2nd-generation devices) free passage of an orogastric tube or a negative bubble test. 7. Measure oropharyngeal leak pressure and confirm it exceeds the anticipated peak airway pressure for the case by a comfortable margin; if it does not, escalate device size, generation, or convert to an endotracheal tube.
Manufacturer adult sizing reference (LMA-type devices, approximate — always confirm against the specific device's IFU): Size 3 — 30–50 kg — small adult — max cuff volume ≈ 20 mL (air-inflated types) Size 4 — 50–70 kg — average adult — max cuff volume ≈ 30 mL Size 5 — 70–100 kg (some IFUs to 120 kg) — large adult — max cuff volume ≈ 40 mL Target intracuff pressure by manometer: 40–60 cmH₂O regardless of size — inflate to seal, not to a fixed number of milliliters.
Correct insertion technique is what turns a correctly chosen, correctly sized device into a functioning airway. The device is guided along the natural curve of the hard and soft palate, past the base of the tongue, and into the hypopharynx until resistance is felt at the upper esophageal sphincter — at which point the bowl of the device lies directly over the laryngeal inlet, with the cuff (or gel cushion) sealing the space around it.
With the patient adequately anesthetized (loss of eyelash reflex and jaw relaxation are useful bedside signs), the head is placed in a neutral or slightly extended "sniffing" position. The device — cuff deflated and lubricated on its posterior surface for cuffed types, or used dry per manufacturer instruction for gel-cushion types — is held like a pen at the junction of tube and bowl.
The tip is pressed against the hard palate immediately behind the upper incisors and advanced in a single smooth motion, maintaining contact with the palate and posterior pharyngeal wall, rotating the wrist as the device follows the natural curve down past the tongue base. The non-dominant hand may extend the neck slightly or retract the jaw to ease passage. Advancement continues until a definite increase in resistance is felt, signaling the tip has reached the upper esophageal sphincter and can go no further — this is the fully seated position, not a depth to be forced past.
For inflatable-cuff devices, the cuff is inflated with just enough air to achieve a seal — guided by cuff manometry to a target of 40–60 cmH₂O rather than a fixed syringe volume marked on the device packaging, which is a maximum, not a target. Overinflation does not improve the seal beyond a certain point and directly increases mucosal pressure injury risk. Gel-cushion devices (i-gel) require no inflation at all; the thermoplastic elastomer softens at body temperature and conforms to the periglottic anatomy passively.
Correct seating is suggested by: a slight outward movement of the tube as the cuff inflates and seats itself, an easily palpable, symmetric neck bulge is absent (a bulge suggests malposition), and — most importantly — effective ventilation with square-wave capnography once connected to the breathing circuit. For second-generation devices, passage of a lubricated orogastric tube through the drain port with free advance into the stomach is strong confirmatory evidence of correct tip position relative to the esophagus.
Common malposition patterns include the epiglottis folding down into the bowl (down-folded epiglottis), the tip failing to reach the esophagus and instead lodging in the vallecula, or lateral rotation of the device off the midline. Signs include a poor or absent capnography trace, high inflation pressures with minimal chest rise, gas leak audible at the mouth despite adequate cuff pressure, or gastric insufflation sound over the epigastrium.
Management is typically straightforward: deflate the cuff partially, withdraw the device 2–3 cm, and re-advance with a slightly different jaw position or head extension; a jaw-thrust maneuver during reinsertion often resolves epiglottic downfolding. If two reasonable attempts fail, escalate to a different device size or generation, or proceed to alternative airway management (video laryngoscopy, endotracheal intubation) rather than repeating the same failed technique.
The insertion motion should never require force. Resistance during advancement almost always signals either correct arrival at the esophageal sphincter (stop) or an anatomic obstruction/malrotation (withdraw and reassess) — forcing the device past resistance is a common cause of mucosal trauma and bleeding that can itself compromise the airway.
The final and arguably most safety-critical step is objective confirmation that the device is not only correctly positioned but functionally adequate for the ventilation the procedure will demand. This rests on three converging signals — visible chest rise, a normal capnography waveform, and a measured oropharyngeal leak pressure with a comfortable margin above the anticipated peak airway pressure — rather than any single sign in isolation.
Immediately after connection to the breathing circuit, bilateral, symmetric chest rise with each positive-pressure breath (or with each spontaneous effort) is the first bedside sign of adequate ventilation. Auscultation over both lung fields confirms equal air entry and excludes the (uncommon, but possible with a malpositioned device or unrecognized bronchial migration in small patients) scenario of unilateral ventilation.
Capnography is the definitive real-time confirmation. A normal square waveform — a rapid upstroke, a plateau near 35–45 mmHg, and a rapid downstroke on inspiration — confirms that CO₂-containing gas is being reliably exchanged through the device on every breath. A low, absent, or progressively downsloping trace (rather than a clean plateau) suggests a leak large enough to compromise ventilation, malposition, or a partially obstructed airway, and should prompt immediate reassessment before proceeding with surgery.
Leak pressure is measured by closing the adjustable pressure-limiting (APL) valve on the breathing circuit, setting a fixed fresh gas flow (commonly 3 L/min), and slowly watching airway pressure rise on the manometer while listening over the mouth and trachea for an audible gas leak. The pressure at which a leak is first heard, or at which airway pressure plateaus despite continued flow, is the leak pressure for that device in that patient.
This single number is the practical ceiling on how much positive-pressure ventilation the device can deliver without gas escaping around the cuff — and, by the same physical principle, provides an inverse indication of how well the seal would resist reflux moving in the opposite direction. A leak pressure that only marginally exceeds the ventilation pressure the procedure will require leaves no safety margin for the pressure spikes that coughing, straining, patient movement, or a surgical retractor against the diaphragm can produce.
A widely used working rule is to require the measured leak pressure to exceed the anticipated peak inspiratory pressure for the procedure by a clear margin — commonly cited as at least 5 cmH₂O, with a larger margin favored for laparoscopic, robotic, or Trendelenburg cases where intra-abdominal pressure and required ventilating pressure are both elevated and prone to intraoperative change.
If leak pressure is inadequate: first confirm optimal device seating (reposition, adjust cuff pressure to the 40–60 cmH₂O target rather than simply adding more air) before concluding the device itself is unsuitable. If repositioning and correct cuff pressure do not close the margin, escalate to a larger size, a second-generation device with a higher intrinsic seal pressure, or abandon the supraglottic approach altogether in favor of a cuffed endotracheal tube — particularly if the shortfall is combined with any aspiration risk factors identified at the start of the case.
Throughout the procedure, the leak-pressure margin should be treated as a live safety parameter, not a one-time checkbox: a margin that was adequate at induction can be eroded by patient repositioning, surgical insufflation, or device migration, and should be reassessed if airway pressures or capnography change unexpectedly.
A device that passes chest rise and capnography at low pressure can still fail during a pressure spike later in the case. The leak-pressure margin — not just the presence of a waveform — is what tells you whether the device will hold up when the procedure actually demands it.